Author

Simon Collins

Observed institutions: The Royal Free Hospital, Medical Research Council

OpenAlex ID: A5124879167

Persistence of HIV-1 Transmitted Drug Resistance Mutations

2013 · Hannah Castro, Hannah Castro, et al. · The Journal of Infectious Diseases · 105

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom

2016 · Ellen White, Ellen White, et al. · The Journal of Infectious Diseases · 14

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial

2026 · Ming J Lee, Louise-Rae Cherrill, et al. · The Lancet HIV · 5

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus

2026 · Tommaso Clemente, Arjen J Stam, et al. · The Lancet HIV · 4

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy

2026 · Mohammed Altaf, Carla Nel, et al. · medRxiv · 4

Works count: 6

Citation count: 136

H-index: 4

I10-index: 2